A share price of Chemours Company [CC] is currently trading at $15.07, up 2.87%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CC shares have gain 23.73% over the last week, with a monthly amount glided 13.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Chemours Company [NYSE: CC] stock has seen the most recent analyst activity on March 27, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $19 for it. Previously, Truist started tracking the stock with Buy rating on January 28, 2025, and set its price target to $27. On July 09, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $30 on the stock. Mizuho started tracking the stock assigning a Neutral rating and suggested a price target of $25 on June 07, 2024. BMO Capital Markets upgraded its rating to a Outperform and raised its price target to $34 on April 09, 2024. UBS downgraded its rating to Neutral for this stock on March 05, 2024, and downed its price target to $21. In a note dated February 29, 2024, BMO Capital Markets downgraded an Underperform rating on this stock and revised its target price from $45 to $19.
Chemours Company experienced fluctuations in its stock price throughout the past year between $9.13 and $22.38. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Chemours Company [NYSE: CC] shares were valued at $15.07 at the most recent close of the market. An investor can expect a potential return of 6.17% based on the average CC price forecast.
Analyzing the CC fundamentals
Trailing Twelve Months sales for Chemours Company [NYSE:CC] were 5.88B which represents 5.01% growth. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.81 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.35 points at the first support level, and at 13.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.54, and for the 2nd resistance point, it is at 16.02.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Chemours Company [NYSE:CC] is 1.68. Also, the Quick Ratio is 0.83, while the Cash Ratio stands at 0.27. Considering the valuation of this stock, the price to sales ratio is 0.38, the price to book ratio is 9.52.
Transactions by insiders
Recent insider trading involved Dignam Denise, President & CEO, that happened on Aug 08 ’25 when 4068.0 shares were purchased. Gumpel Damian completed a deal on Jun 02 ’25 to buy 13400.0 shares. Meanwhile, Gumpel Damian bought 7822.0 shares on Jun 03 ’25.
